Memorial Sloan Kettering Cancer Center

GSK’s Jemperli leads to sustained clinical complete responses in 95% of rectal cancer patients

BioCentury’s roundup of translational innovations also includes boosting T cell antitumor activity via fructose, and a new Parkinson’s risk gene

San Francisco Bay Area biotech has two antibody platforms designed to improve on the potency and safety of bispecifics

BioCentury’s roundup of translational innovations also includes causal biology for a heart condition, and the biological foundational model Evo 2

BioCentury’s roundup of translational innovations also includes a human hypothalamus atlas from Novo and collaborators, and four papers with links to newcos

BioCentury’s roundup of translational innovations also includes a study from Amgen and a newco spotlight

Highlander Institute, headed by former Verily executives, announces first grants

Plus: Glaub, Enright become CEO, chair at CuraSen and updates from Volastra, Essential Pharma and Transpire